AM Bio Tech

AM Biotech is a biotechnology company specializing in the development of X-Aptamers, a next-generation class of chemically modified aptamers. Based in Pearland, Texas, the company utilizes a proprietary platform to create high-affinity ligands that incorporate drug-like modifications, overcoming the limitations of traditional SELEX-derived aptamers. These molecules are designed for use in proteomics, diagnostics, and as potential therapeutic leads across various disease areas including oncology and inflammation. AM Biotech offers custom aptamer selection services and collaborates with academic and industrial partners to accelerate biomarker discovery. The company's technology is supported by an extensive portfolio of patents and has been validated through numerous federal research grants.